TcdC does not significantly repress toxin expression in Clostridium difficile 630δErm

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Bakker, Dennis ^a   Smits, Wiep Klaas ^a   Kuijper, Ed J ^a   Corver, Jeroen ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM TOXIN;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; CLOSTRIDIUM DIFFICILE; COISOGENIC STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; NONHUMAN; PALOC GENE; PATHOGENICITY; TCDC GENE; TOXIN ANALYSIS; TOXIN SYNTHESIS; WILD TYPE;

BACTERIAL PROTEINS; BACTERIAL TOXINS; BLOTTING, WESTERN; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; REPRESSOR PROTEINS;

EID: 84865074510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043247     Document Type: Article

References (45)

1. Goorhuis A, van der Kooi T, Vaessen N, Dekker FW, van den Berg R, et al. (2007) Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 45: 695-703.
2. Kuijper EJ, Coignard B, Tull P, (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12 Suppl 6: 2-18.
3. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442-2449.
4. Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, et al. (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 13.
5. Paltansing S, van den Berg RJ, Guseinova RA, Visser CE, van der Vorm ER, et al. (2007) Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect 13: 1058-1064.
6. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171: 466-472.
7. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, et al. (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377: 63-73.
8. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, et al. (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47: 1162-1170.
9. Wilcox MH (2009) Clostridium difficile Ribotyping Network for England and Northern Ireland.
10. Just I, Gerhard R, (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152: 23-47.
11. Mani N, Dupuy B, (2001) Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98: 5844-5849.
12. Matamouros S, England P, Dupuy B, (2007) Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64: 1274-1288.
13. Voth DE, Ballard JD, (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18: 247-263.
14. Tan KS, Wee BY, Song KP, (2001) Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol 50: 613-619.
15. Curry SR, Marsh JW, Muto CA, O'Leary MM, Pasculle AW, et al. (2007) tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 45: 215-221.
16. Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, et al. (1997) Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 244: 735-742.
17. Dupuy B, Sonenshein AL, (1998) Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27: 107-120.
18. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192: 4904-4911.
19. Vohra P, Poxton IR, (2011) Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157: 1343-1353.
20. Govind R, Vediyappan G, Rolfe RD, Fralick JA, (2006) Evidence that Clostridium difficile TcdC is a membrane-associated protein. J Bacteriol 188: 3716-3720.
21. Mani N, Lyras D, Barroso L, Howarth P, Wilkins T, et al. (2002) Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression. J Bacteriol 184: 5971-5978.
22. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079-1084.
23. Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T, (2000) Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun 68: 5881-5888.
24. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP, (2007) The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods 70: 452-464.
25. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, et al. (2010) The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods 80: 49-55.
26. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, et al. (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467: 711-713.
27. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331: 991-1004.
28. O'Connor JR, Johnson S, Gerding DN, (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924.
29. Lyerly DM, Sullivan NM, Wilkins TD, (1983) Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol. 17: 72-78.
30. Carter GP, Douce GR, Govind R, Howarth PM, Mackin KE, et al. (2011) The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile. PLoS Pathog 7: e1002317.
31. Metcalf D, Sharif S, Weese JS, (2010) Evaluation of candidate reference genes in Clostridium difficile for gene expression normalization. Anaerobe 16: 439-443.
32. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
33. Graeber K, Linkies A, Wood AT, Leubner-Metzger G, (2011) A guideline to family-wide comparative state-of-the-art quantitative RT-PCR analysis exemplified with a brassicaceae cross-species seed germination case study. Plant Cell 23: 2045-2063.
34. Hussain HA, Roberts AP, Mullany P, (2005) Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J Med Microbiol 54: 137-141.
35. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. (2006) The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38: 779-786.
36. Ho TD, Ellermeier CD, (2011) PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile. Infect Immun 79: 3229-3238.
37. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176-1179.
38. Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP, (2012) Precise Manipulation of the Clostridium difficile Chromosome Reveals a Lack of Association between the tcdC Genotype and Toxin Production. Appl Environ Microbiol 78: 4683-4690.
39. Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ, (2009) Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect Dis. 9: 103.
40. Garnier T, Cole ST, (1986) Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene. J Bacteriol 168: 1189-1196.
41. Purdy D, O'Keeffe TA, Elmore M, Herbert M, McLeod A, et al. (2002) Conjugative transfer of clostridial shuttle vectors from Escherichia coli to Clostridium difficile through circumvention of the restriction barrier. Mol Microbiol 46: 439-452.
42. Wren BW, Tabaqchali S, (1987) Restriction endonuclease DNA analysis of Clostridium difficile. J Clin Microbiol 25: 2402-2404.
43. Deckers-Hebestreit G, Altendorf K, (1986) Accessibility of F0 subunits from Escherichia coli ATP synthase. A study with subunit specific antisera. Eur J Biochem 161: 225-231.
44. Knetsch CW, Terveer EM, Lauber C, Gorbalenya AE, Harmanus C, et al. (2012) Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect Genet Evol. 15 12(7): 1577-1585.
45. Dawson LF, Donahue EH, Cartman ST, Barton RH, Bundy J, et al. (2011) The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol 11 86: 86.